Oral-Systemic Link: Page 58

Study: Experienced radiation centers have better outcomes for HNC

By DrBicuspid.com staff writers

Experienced radiation centers have better outcomes for patients with head and neck cancer (HNC), according to a new study in the Journal of Clinical Oncology. Researchers found that patients who underwent radiation therapy at treatment centers with less experience had higher cancer recurrence and poorer overall survival.

December 14, 2014

FDA approves Gardasil 9 vaccine for 9 HPV types

By DrBicuspid.com staff writers

The U.S. Food and Drug Administration (FDA) has approved the Gardasil 9 vaccine for preventing certain diseases caused by nine types of human papillomavirus (HPV).

December 10, 2014

Vigiliant marks milestone certification

By DrBicuspid.com staff writers

Vigilant Biosciences has received International Organization for Standardization (ISO) 13485:2003 certification, an internationally recognized quality standard for medical devices.

December 10, 2014

Antacids linked to better survival in HNSCC

By Donna Domino

Patients with head and neck squamous cell carcinoma (HNSCC) who took antacid medicines to control acid reflux had better overall survival in a new study, published in Cancer Prevention Research.

December 10, 2014

Green Day guitarist diagnosed with tonsil cancer

By DrBicuspid.com staff writers

Green Day guitarist Jason White has been diagnosed with tonsil cancer.

December 8, 2014

HPV legislation doesn't increase vaccination among adolescents

By Donna Domino

U.S. legislation that requires or encourages young people to get the human papillomavirus (HPV) vaccine has been unsuccessful in getting more of them vaccinated, according to new research presented at the recent American Public Health Association annual meeting.

November 20, 2014

Lymphoseek earns EU marketing authorization

By DrBicuspid.com staff writers

Navidea Biopharmaceuticals announced that it has received marketing authorization in the European Union (EU) for its Lymphoseek 250-mcg kit for radiopharmaceutical preparation.

November 19, 2014

Global Oral Cancer Forum: An international approach for care, prevention

By Donna Domino

The newly formed Global Oral Cancer Forum recruits international participants to share the issues they face; learn about innovations, models, or ideas to curb growing rates of the disease; and help patients who have treatment complications. The group will gather in New York in September 2015, bringing together international multidisciplinary teams that demonstrate passion and dedication to oral cancer.

November 19, 2014

DrBicuspid.com Oral Cancer & Diagnostics Insider

By Donna Domino

November 12, 2014

Forward Science donates 2nd OralID to Calif. clinic

By DrBicuspid.com staff writers

Forward Science Technologies, the developers of OralID and CytID, has donated a second OralID device as part of its OralID Facebook Charity Campaign to the Free Clinic of Simi Valley in California.

November 12, 2014

Japanese mushroom may help treat HPV infection

By DrBicuspid.com staff writers

A Japanese mushroom extract appears to be effective in eradicating human papillomavirus (HPV), according to a pilot clinical trial at the University of Texas Medical School at Houston

November 12, 2014

PeriRx launches SaliMark oral cancer screening test

By DrBicuspid.com staff writers

PeriRx has launched its SaliMark OSCC salivary DNA test for oral cancer at a continuing education event on Thursday in Havertown, PA, and also plans to introduce the test at the upcoming Greater New York Dental Meeting, held in New York City from November 28 to December 3.

November 5, 2014

Previous Page

Page 58 of 153

Next Page